Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications-A systematic review

被引：7
|
作者：
Ramanathan, Kumaresan [1 ]
Padmanabhan, Giri [2 ]
机构：
[1] Mekelle Univ, Dept Med Biochem, Div Biomed Sci, Sch Med,Coll Hlth Sci, Ayder Campus, Mekelle, Ethiopia
[2] Kidney Care, C50,10th B Cross, Tiruchirappalli, Tamil Nadu, India
来源：
INDIAN HEART JOURNAL | 2020年 / 72卷 / 01期
关键词：
Soluble neprilysin; Biomarker; Heart failure; Diabetic kidney disease; A systematic review; ANGIOTENSIN-CONVERTING ENZYME; VASOPEPTIDASE INHIBITOR OMAPATRILAT; RESUSCITATION COUNCIL GUIDELINES; NEUTRAL ENDOPEPTIDASE; ALDOSTERONE SYNTHESIS; INSULIN SENSITIVITY; CELLS; HYDROLYSIS; MIXANPRIL; FIBROSIS;
D O I：
10.1016/j.ihj.2020.01.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The potential role of soluble neprilysin (sNEP) as a biomarker has been poorly documented. Hence, the present systematic review emphasizes to explore sNEP as an emerging biomarker for heart failure (HF), cardiovascular diseases, diabetic kidney diseases, and so on. A systematic review was performed using an online database search in PubMed, Science Direct, Scopus, and Cochrane Library. Articles reporting biomarker's performance to diagnose various diseases in human participants were included. The results of the search outcome were 4723 articles. Based on the inclusion criteria of the systematic review, finally, 12 articles fulfilled the selection criteria. In these studies, 8 cohort study, 2 cross-sectional study, 1 case econtrol, and 1 prospective cohort study were identified. All these studies clearly suggested sNEP as a potential biomarker for diagnosis of various diseases (HF, cardiovascular diseases, diabetic kidney diseases, metabolic syndrome). sNEP may be a potential biomarker for HF, cardiovascular diseases, diabetic kidney disease, and so on. (C) 2020 Cardiological Society of India. Published by Elsevier B.V.
引用
收藏
页码：14 / 19
页数：6
相关论文
共 50 条
  • [21] Efficacy of Angiotensin Receptor-Neprilysin Inhibitor and Its Renal Outcome in Heart Failure Patients: A Systematic Review of Randomized Clinical Trials
    Almansouri, Naiela E.
    Bakkannavar, Saloni
    Faheem, Youmna
    Jaiswal, Amisha
    Shergill, Kainaat
    Boppana, Kusalik
    Nath, Tuheen Sankar
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [22] SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis
    Cardoso, Rhanderson
    Graffunder, Fabrissio P.
    Ternes, Caique M. P.
    Fernandes, Amanda
    Rocha, Ana, V
    Fernandes, Gilson
    Bhatt, Deepak L.
    [J]. ECLINICALMEDICINE, 2021, 36
  • [23] SGLT2 INHIBITORS DECREASE CARDIOVASCULAR MORTALITY OR HEART FAILURE HOSPITALIZATIONS IN HEART FAILURE SUBGROUPS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Cardoso, Rhanderson
    Graffunder, Fabrissio P.
    Ternes, Caique M. P.
    Fernandes, Gilson
    Rocha, Ana Vitoria
    Bhatt, Deepak
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 655 - 655
  • [24] Prevalence, Incidence and Risk Factors of Chronic Heart Failure in the Type 2 Diabetic Population: Systematic Review
    Zhou, Linuo
    Deng, Wei
    Zhou, Lixue
    Fang, Ping
    He, Daikun
    Zhang, Weiwei
    Liu, Kui
    Hu, Renming
    [J]. CURRENT DIABETES REVIEWS, 2009, 5 (03) : 171 - 184
  • [25] Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis
    Liu, Jingxing
    Hu, Xinhua
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (03):
  • [26] Association of liver stiffness and cardiovascular outcomes in patients with heart failure: A systematic review and meta-analysis
    Khan, Muhammad Shahzeb
    Siddiqi, Tariq Jamal
    Khan, Safi U.
    Shah, Sanjiv J.
    VanWagner, Lisa B.
    Khan, Sadiya S.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (03) : 331 - 334
  • [27] Blood pressure levels and adverse cardiovascular outcomes in heart failure: A systematic review and meta-analysis
    Seidu, Samuel
    Lawson, Claire A.
    Kunutsor, Setor K.
    Khunti, Kamlesh
    Rosano, Giuseppe M. C.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (05) : 1111 - 1124
  • [28] SYSTEMATIC REVIEW OF PREVALENT AND INCIDENT HEART FAILURE IN CARDIOVASCULAR OUTCOME TRIALS OF PATIENTS WITH TYPE 2 DIABETES
    Greene, Stephen
    Vaduganathan, Muthiah
    Khan, Muhammad
    Bakris, George
    Weir, Matthew
    Seltzer, Jonathan
    Sattar, Naveed
    McGuire, Darren
    Januzzi, James
    Stockbridge, Norman
    Butler, Javed
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 797 - 797
  • [29] The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression - a systematic review
    Rajeswaran, Thurkka
    Plymen, Carla M.
    Doherty, Anne M.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2018, 22 (03) : 164 - 169
  • [30] A Systematic Review Exploring the Cardiovascular and Renal Effects of Empagliflozin in Patients With Heart Failure With Reduced Ejection Fraction
    Athiyaman, Sreekartthik
    Randhi, Bhawna
    Gutlapalli, Sai Dheeraj
    Pu, Jingxiong
    Zaidi, Maheen F.
    Patel, Maithily
    Atluri, Lakshmi Malvika
    Gonzalez, Natalie A.
    Sakhamuri, Navya
    Venugopal, Sathish
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
12345